Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure.

@article{Thomas2005CosteffectivenessOE,
  title={Cost-effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure.},
  author={Northcote Whitridge Thomas and Christopher S Hollenbeak and Steven E. Lucking and Douglas F. Willson},
  journal={Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies},
  year={2005},
  volume={6 2},
  pages={
          160-5
        }
}
OBJECTIVE To determine whether the use of exogenous surfactant (Infasurf) in pediatric acute hypoxemic respiratory failure is cost-effective. DESIGN Deterministic cost-effectiveness analysis based on a Markov model. The model was calibrated using outcomes and resource utilization observed in a multiple-centered, prospective, randomized, controlled unblinded trial of Infasurf in pediatric acute hypoxemic respiratory failure. Costs were short-run direct costs estimated from the perspective of… CONTINUE READING

From This Paper

Topics from this paper.

References

Publications referenced by this paper.

Cost - effectiveness of exogenous surfactant therapy in pediatric patients with acute hypoxemic respiratory failure

  • DF Willson, A Zaritshy, LA Bauman
  • Pediatric Critical Care Medicine
  • 2005

Similar Papers

Loading similar papers…